Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Basilea grants Pfizer European license to Cresemba; rights now include China and Asia Pacific

Executive Summary

Basilea Pharmaceutica Ltd. licensed Pfizer Inc. exclusive rights to commercialize and distribute the antifungal Cresemba (isavuconazole) in European countries including Austria, France, Germany, Italy, and the UK, all territories where the drug is already being sold.

Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Royalty or Profit Split Information
    • Marketing (Licensing)

Related Companies